Search results for 'drug manufacturing'

Covid vaccine to cost Rs 290 to govt; Rs 585 in pvt mkt: Serum

Covid vaccine to cost Rs 290 to govt; Rs 585 in pvt mkt: Serum

Rediff.com4 Jan 2021

Serum Institute of India, the world's largest vaccine manufacturer, has a licence to produce the shot and has already manufactured close to 50 million doses.

COVID-19 vaccines don't belong to any political party: Omar Abdullah

COVID-19 vaccines don't belong to any political party: Omar Abdullah

Rediff.com2 Jan 2021

The more people get vaccinated, the better it will be for the country and the economy, the National Conference vice president said.

Emerging AI: What Awaits Us?

Emerging AI: What Awaits Us?

Rediff.com13 Dec 2022

Ajit Balakrishnan offers lessons from another tech revolution not so long ago.

Govt in talks with Pfizer, J&J for supply of vaccines to India

Govt in talks with Pfizer, J&J for supply of vaccines to India

Rediff.com2 Jun 2021

The central government is importing COVID-19 vaccines and is in talks with COVID-19 vaccine manufacturers Pfizer and Johnson & Johnson, Union Minister of State for Home Affairs G Kishan Reddy said.

Govt looking into securing part of J&J vaccines: Sources

Govt looking into securing part of J&J vaccines: Sources

Rediff.com26 May 2021

According to the sources, there are limited prospects of J&J exporting its vaccine from the US to other countries in the near future and the "entire production" at the BE facilities in India, beginning July/August, will be handed over to the pharma giant under a contract between the companies.

Private hospitals may import Covid vaccines

Private hospitals may import Covid vaccines

Rediff.com15 May 2021

Apollo Hospitals and Fortis Healthcare are open to importing vaccines.

Another Indian COVID-19 vaccine candidate gets nod for human trial

Another Indian COVID-19 vaccine candidate gets nod for human trial

Rediff.com3 Jul 2020

Zydus plans to initiate the clinical trials of ZyCoV-D in July 2020 across multiple sites in India. In animal studies the vaccine was found to elicit a strong immune response in multiple animal species like mice, rats, guinea pigs and rabbits.

Setback for Sanjiv Bhatt as Gujarat HC dismisses plea in NDPS case

Setback for Sanjiv Bhatt as Gujarat HC dismisses plea in NDPS case

Rediff.com6 Aug 2021

The Gujarat high court has dismissed a revision application filed by sacked IPS officer Sanjiv Bhatt, seeking modification in the charges framed against him in a 1996 case under the Narcotics Drugs and Psychotropic Substances Act (NDPS).

'Famotidine may become the next HCQ for Covid-19'

'Famotidine may become the next HCQ for Covid-19'

Rediff.com10 May 2020

Researchers at Northwell Health in New York are testing the effects on Famotidine (used in high intravenous doses) on Covid-19 patients as a potential treatment. After the hospital announced its clinical trials, it led to a drug shortage in the US. Back home, however, there has not been any surge in the demand for Famotidine yet.

Hydroxychloroquine consignment from India arrives in US

Hydroxychloroquine consignment from India arrives in US

Rediff.com12 Apr 2020

Hydroxychloroquine has been identified by the US Food and Drug Administration as a possible treatment for the COVID-19 and it is being tested on more than 1,500 coronavirus patients in New York.

Gujarat firm gets licence to make covid-19 test kits

Gujarat firm gets licence to make covid-19 test kits

Rediff.com22 Mar 2020

A joint venture of Synbiotics, a wholly owned subsidiary of Ambalal Sarabhai Enterprises (ASE), and CoDiagnostics, CoSara Diagnostics is the first and only Indian company so far to receive a licence from the Central Drugs Standard Control Organisation (CDSCO) to manufacture coronavirus diagnostic test kits.

India to start world's biggest vaccination drive: PM

India to start world's biggest vaccination drive: PM

Rediff.com4 Jan 2021

Lauding the scientists and technicians for the 'Made in India' vaccines, he said the country is proud of them.

Why prices of vitamin C, antibiotics could shoot up

Why prices of vitamin C, antibiotics could shoot up

Rediff.com14 Dec 2019

The government said that "in exercise of extraordinary powers in public interest, conferred by paragraph 19 of the DPCO, 2013", the ceiling prices of 21 key formulations had been increased. These formulations include common medicines like BCG vaccines, penicillin, malaria and leprosy medicines (Dapsone), life-saving drugs like Furosemide (used to treat fluid build-up due to heart failure, liver scarring, or kidney disease), vitamin C, some common antibiotics, and anti-allergy medicines.

Economic recovery still not well entrenched: RBI Guv

Economic recovery still not well entrenched: RBI Guv

Rediff.com16 Sep 2020

Observing that the economic recovery was not yet fully entrenched, the RBI Governor said recovery is likely to be gradual.

Centre orders 2.22 cr PPE; 1.43 cr to be made domestically

Centre orders 2.22 cr PPE; 1.43 cr to be made domestically

Rediff.com1 May 2020

Addressing a press briefing on the COVID-19 situation in the country, P D Vaghela, Chairman of the Empowered Group-3, said about 19,398 ventilators are available in India and orders have been placed for 60,884 more, and of these 59,884 will be made by domestic manufacturers.

India has developed first DNA vaccine for COVID-19: Modi @ UNGA

India has developed first DNA vaccine for COVID-19: Modi @ UNGA

Rediff.com25 Sep 2021

Prime Minister Narendra Modi, in his address at the 76th session of the United Nations General Assembly on Saturday, invited the global manufacturers of vaccines to come and make vaccines in India, stressing that the country's "faith is to serve people".

Nestle's cumin extract patent bid raises hackles

Nestle's cumin extract patent bid raises hackles

Rediff.com8 Jan 2014

Company claims new use for kala jeera extract, provoking alarmed campaigners here and abroad; says reaction not based on facts.

Covid-19 could be the boost Indian pharma cos need

Covid-19 could be the boost Indian pharma cos need

Rediff.com20 Sep 2020

The western world had largely considered India to be a production hub, and also, a good potential geography for clinical trials, and a big market. But in Covid-19 research, Indian companies and government researchers are also researching new drug candidates and potential vaccines, says Prosenjit Datta.

AP drug makers major polluters

AP drug makers major polluters

Rediff.com3 Sep 2007

A study by a Swedish University has accused India's Active Pharmaceutical Ingredient (API) manufacturers of causing alarming levels of environmental pollution and threatening the region's flora and fauna.

Covaxin maker to pay compensation in case of side effects

Covaxin maker to pay compensation in case of side effects

Rediff.com16 Jan 2021

"The compensation for serious adverse event will be paid by sponsor (BBIL) in case if the SAE is proven to be causally related to the vaccine," the consent form said.

Every Ruling Party Like Its Writ To Run

Every Ruling Party Like Its Writ To Run

Rediff.com24 Jun 2023

Despite their opposition based on ideology, both the political Right and the political Left possess similar behaviour, observes Shyam G Menon.

It's Raining Billions For Gujarat!

It's Raining Billions For Gujarat!

Rediff.com3 Nov 2022

Hemant Shivsaran lists the number of projects the Modi government has announced since August to woo Gujarat voters.

Covaxin for kids: Bharat Biotech completes phase 2/3 trials

Covaxin for kids: Bharat Biotech completes phase 2/3 trials

Rediff.com21 Sep 2021

Bharat Biotech has completed the Phase 2/3 trials of COVID-19 vaccine, Covaxin for use in children under 18 years of age and is expected to submit the data by next week to the Drugs Controller General of India (DCGI), Chairman and Managing Director of Bharat Biotech International Ltd, Krishna Ella said

Modi govt firm to help Bengal fight Covid: Vardhan to Mamata

Modi govt firm to help Bengal fight Covid: Vardhan to Mamata

Rediff.com8 May 2021

With West Bengal Chief Minister Mamata Banerjee seeking a uniform vaccination policy for the country, Union Health Minister Harsh Vardhan on Friday assured her that the Modi government was firm in its resolve to help the state fight the COVID-19 pandemic, but also flagged more than 40 per cent positivity rate in some districts of the state.

Govt waives import duty on Remdesivir

Govt waives import duty on Remdesivir

Rediff.com20 Apr 2021

This import duty exemption would remain in force till October 31 this year.

Biocon Biologics Plan Molecule Launch Every 1-2 Years

Biocon Biologics Plan Molecule Launch Every 1-2 Years

Rediff.com17 Aug 2022

'The tie-up with Serum Institute Life Sciences brings to the table their strengths in manufacturing and also their vaccine portfolio.'

US FDA India head quits; regulator goes for rejig

US FDA India head quits; regulator goes for rejig

Rediff.com21 Jul 2014

Altaf Ahmed Lal, country head of the US Food and Drug Administration (US FDA) in India, has quit and so have a few other key officials at the American drug regulator's India office.

Covaxin phase 3 trial data to be published in July: Bharat Biotech

Covaxin phase 3 trial data to be published in July: Bharat Biotech

Rediff.com9 Jun 2021

Hyderabad-based vaccine manufacturer Bharat Biotech, which is carrying out its phase 3 trial will publish the data in July following that the company will be applying for the full licensure of Covaxin.

P&G stops sale of 'Vicks Action 500 Extra' after govt ban

P&G stops sale of 'Vicks Action 500 Extra' after govt ban

Rediff.com15 Mar 2016

Drug majors Pfizer and Abbott stopped sale of their popular cough syrups Corex and Phensedyl respectively.

Why Sun Pharma stock will remain under pressure

Why Sun Pharma stock will remain under pressure

Rediff.com24 Dec 2019

The weakness in the stock was because of inspections by the American drug regulator at its Halol plant in Gujarat which resulted in eight observations, as well as a downward revision of speciality drug payoffs.

With Sharapova's admission, many cans of worms will open

With Sharapova's admission, many cans of worms will open

Rediff.com12 Mar 2016

'The suspicion of doping will hang over numerous men and women players including the elite stars,' says Desh Gaurav Chopra Sekhri.

India's first COVID-19 vaccine gets nod for human trials

India's first COVID-19 vaccine gets nod for human trials

Rediff.com30 Jun 2020

COVAXIN, developed by Hyderabad-based Bharat Biotech in collaboration with Indian Council of Medical Research and National Institute of Virology, has got the nod for human clinical trials from the Drug Controller General of India

How complex is the process of getting approval for a vaccine?

How complex is the process of getting approval for a vaccine?

Rediff.com30 Sep 2020

Vaccine development is a long process to ensure safety and efficacy through different stages and involves regulatory supervision every step of the way. Ruchika Chitravanshi takes you through this carefully drawn journey of vaccine development.

Phase 3 trial of Oxford vaccine to begin in Pune from next week

Phase 3 trial of Oxford vaccine to begin in Pune from next week

Rediff.com19 Sep 2020

"The phase-III trial of 'Covishield' vaccine will begin at Sassoon hospital from next week. It is likely to start on Monday. Some volunteers have already come forward for the trial. "Around 150 to 200 volunteers will be administered the vaccine candidate dose," Dean of the state-run Sassoon General Hospital Dr Muralidhar Tambe said.

Bombay HC: Cannabis plant can't be considered 'ganja' if...

Bombay HC: Cannabis plant can't be considered 'ganja' if...

Rediff.com4 Sep 2022

A seized cannabis plant without flowering or fruiting tops does not fall under the purview of 'ganja', the Bombay high court has ruled while granting pre-arrest bail to a man accused of possessing commercial quantity of the narcotic substance.

India to supply Covid vaccines to 6 countries as aid

India to supply Covid vaccines to 6 countries as aid

Rediff.com19 Jan 2021

In a tweet, Prime Minister Narendra Modi said India is deeply honoured to be a 'long-trusted' partner in meeting the healthcare needs of the global community and that supplies of the vaccines to several countries will commence on Wednesday, and more will follow in the days ahead.

GDP likely to fall to 30-year low, fear analysts

GDP likely to fall to 30-year low, fear analysts

Rediff.com27 Mar 2020

In the manufacturing sector, output is expected to decline by about 70 per cent as only food-processing, and drugs and pharma industries are allowed to operate while other segments, such as engineering and metals, have shut operations.

UK's new antibody treatment against Covid may work against Omicron

UK's new antibody treatment against Covid may work against Omicron

Rediff.com2 Dec 2021

The UK's medicines regulator on Thursday approved a new antibody treatment against COVID-19, which it believes will also be effective against new variants such as Omicron.

India's richest club sees nine new entrants; Ambani still No 1

India's richest club sees nine new entrants; Ambani still No 1

Rediff.com9 Oct 2020

Half of the nation's 100 richest saw gains rising a collective 14% to $517.5 billion, says Forbes. Forbes released 2020's top 100 richest Indians on Thursday, which included newcomers, Sanjeev Bikhchandani, co-founder of Info Edge (India), who owns popular job and property websites; siblings Nithin and Nikhil Kamath, co-founders of discount stock brokerage Zerodha Broking, and three specialty chemicals producers - Vinod Saraf, founder of Vinati Organics, Arun Bharat Ram, the patriarch of SRF, and brothers Chandrakant and Rajendra Gogri of Aarti Industries. Other newcomers included Delhi-based brothers Ramesh Kumar and Mukand Lal Dua of Relaxo Footwears, which owns affordable footwear brands; dairyman, R G Chandramogan of Hatsun Agro; Premchand Godha, who chairs IPCA Laboratories, manufacturing formulations, bulk drugs and drug intermediates; G Rajendran, founder of jewellery chain, GRT Jewellers.

WHO meet next week to discuss Covaxin approval

WHO meet next week to discuss Covaxin approval

Rediff.com18 Oct 2021

The World Health Organisation's technical advisory group will meet on October 26 to consider the Emergency Use Listing (EUL) of Covaxin, a vaccine developed by Hyderabad-based Bharat Biotech protecting against COVID-19, the global health agency's chief scientist said.